Posted on 11/20/19
Mevion Signs Agreement to Bring Proton Therapy to Central Taiwan
LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems today announced it had signed a collaborative framework agreement with Chung Shan Medical University Hospital and ASYS Corp to provide advanced . . .
Posted on 11/19/19
Ametros Creates Industry-Leading Regulatory Advisory Council
WILMINGTON, Mass.--(BUSINESS WIRE)--Ametros, the leader in Medicare Set Aside professional administration, has established an expert Regulatory Advisory Council. Led by the company’s Senior Managing Director, Paul . . .
Posted on 11/19/19
Vertex Pharmaceuticals Is A Strong Buy
SummaryVRTX has earned quite a lot of traction driven by the rapid approval of its triple combo Cystic Fibrosis regimen, Trikafta.VRTX delivered a stellar performance in . . .
Posted on 11/19/19
NeuroMetrix Announces One-for-Ten Reverse Split
WOBURN, Mass., Nov. 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) today announced the effectiveness of a one-for-ten reverse split of its common stock. The shares . . .
Posted on 11/19/19
Karuna Therapeutics Proposes Public Offering of Common Stock
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling . . .
Posted on 11/18/19
Phio Pharmaceuticals Announces Pricing of $1.0 Million Public Offering of Common Stock
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic platform, today announced . . .
Posted on 11/18/19
InVivo Therapeutics Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) today announced that it has commenced a proposed public offering of shares of its common stock, par value . . .
Posted on 11/18/19
Nexcelom Supports Biotech Startups with a Donation of Five Cellometer Auto 2000
Nexcelom Biosciences announced the donation of five Cellometer Auto 2000 Automated Cell Viability Counters to LabCentral. This will support advances in cell-based assays and cellular analysis. . . .
Posted on 11/18/19
Frequency Therapeutics Provides Business Updates and Reports Third Quarter 2019 Financial Results
WOBURN, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a . . .
Posted on 11/18/19
Wellington Management Announces Close of Biomedical Innovation Fund I at $393M
Wellington Management, one of the world’s largest independent investment management firms, today announced the final close of the oversubscribed Wellington Biomedical Innovation Fund I.
Posted on 11/18/19
Alkermes to Acquire Rodin Therapeutics
Alkermes plc (Nasdaq: ALKS) and Rodin Therapeutics, Inc. (Rodin) today announced that they have entered into a definitive agreement under which Alkermes will acquire Rodin
Posted on 11/18/19
Freudenberg Medical Launches Wave of Product and Process Innovations
GLOUCESTER, Mass.--(BUSINESS WIRE)--Freudenberg Medical, a global developer and manufacturer of medical devices, components, and minimally invasive solutions, has launched a major innovation initiative - backed by . . .
Posted on 11/18/19
CVS: The Upside Is Still There
SummaryI've received a few questions regarding CVS Health following the latest surge in share prices and whether I've changed my stance from bullish.CVS currently trades at . . .
Posted on 11/18/19
Here's What Warren Buffett's Berkshire Hathaway is Buying and Selling Now
Berkshire Hathaway's (NYSE:BRK-A) (NYSE:BRK-B) stock portfolio is perhaps the most closely watched in the entire world -- and for good reason. Many of the investments in . . .
Posted on 11/18/19
Yield10 Bioscience Announces Pricing of $10.75 Million Equity Offering
WOBURN, Mass., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) an agricultural bioscience company which uses its “Trait Factory” to develop high value seed . . .
Posted on 11/18/19
Medicinal Genomics Signs Tagaca SRL as Distribution Partner
Medicinal Genomics Corp. (MGC), a pioneer in genomics and blockchain technology to improve the yield, safety and transparency of cannabis, today announced its partnership with Tagaca . . .
Posted on 11/18/19
Devoted Health Named a 2019 Best Places To Work in Boston
WALTHAM, Mass.--(BUSINESS WIRE)--Devoted Health (www.devoted.com), a Medicare startup that’s transforming healthcare for seniors, has been named one of the “Top Places to Work” in the 12th . . .
Posted on 11/18/19
The Boston Globe Names Beam Therapeutics a Top Place to Work For 2019
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, has been named one of the Top Places to Work in Massachusetts . . .
Posted on 11/14/19
Exicure and Allergan Enter Into Collaboration
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc., (NASDAQ:XCUR) a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA) technology, today announced that Allergan’s wholly-owned . . .
Posted on 11/14/19
Charles River Laboratories: Headwinds Ahead But That's Okay
SummaryCharles River reported Q3 2019 results that were well-received by the market. The company beat on the bottom-line but slightly missed the consensus revenue estimate.Acquisitions and . . .
Posted on 11/13/19
CarePort Health Launches Epic EHR Integration
BOSTON--(BUSINESS WIRE)--CarePort Health, a pioneer in care coordination and post-acute outcomes management, today announced that CarePort Guide, its post-acute provider database and patient choice application, is . . .
Posted on 11/13/19
X-Biotix Therapeutics Announces Corporate Progress and Successful Fundraise
WALTHAM, Mass.--(BUSINESS WIRE)--X-Biotix Therapeutics, Inc. (X-Biotix), a biotechnology company focused on the discovery and development of small molecule antibiotic compounds targeting multidrug-resistant (MDR) Gram-negative pathogens, announced . . .
Posted on 11/13/19
KalVista Pharmaceuticals Provides Business Update
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease . . .
Posted on 11/13/19
Seniorlink to Collaborate with the RAND Corporation
Seniorlink, Inc., a leading tech-enabled health services company, formed a collaboration with the RAND Corporation (www.rand.org) to conduct a research study and write a white paper . . .
Posted on 11/13/19
Finch Therapeutics & Takeda Expand Collaboration
SOMERVILLE, Mass.--(BUSINESS WIRE)--Finch Therapeutics Group, Inc. and Takeda Pharmaceutical Company Limited announced today the expansion of their collaboration to develop microbiome-based therapeutics using Finch’s Human-First Discovery platform. Under the . . .

